4 completed, 1 recruiting. 2 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow desidustat: new trials by email Literature Review of desidustat trials Research Report on desidustat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) Desidustat - Chronic Kidney Diseases, Anemia of Chronic Kidney Disease | Phase 4 | Recruiting | Zydus Lifesciences Limited | 1004 | 2023-04-20 | 2025-01-22 |
| Desidustat in the Treatment of Chemotherapy Induced Anemia Desidustat - Anemia of Chronic Kidney Disease, Chemotherapy Effect | Phase 1 | Completed | Zydus Lifesciences Limited | 24 | 2020-11-11 | 2022-05-18 |
| Desidustat in the Management of COVID-19 Patients Desidustat, Standard of Care - COVID-19 | Phase 2 | Completed | Zydus Lifesciences Limited | 24 | 2020-07-25 | 2021-04-23 |
| Desidustat in the Treatment of Anemia in CKD on Dialysis Patients Desidustat Oral Tablet, Epoetin Alfa - Chronic Kidney Disease Stage 5 on Dialysis | Phase 3 | Completed | Zydus Lifesciences Limited | 392 | 2020-01-04 | 2021-11-24 |
| Desidustat in the Treatment of Anemia in CKD Desidustat Oral Tablet, Darbepoetin Alfa - Chronic Kidney Disease Stage 3, Anemia | Phase 3 | Completed | Zydus Lifesciences Limited | 588 | 2019-07-20 | 2021-11-24 |
Renal Insufficiency, Chronic (2) · Anemia (1) · COVID-19 (1)
Zydus Lifesciences Limited (5)
India (4) · Mexico (1)
Dr Deven Parmar, MD (3) · Dr. Deven Parmar, MD,FCP (1) · DrDeven Parmar, MD (1)